Form 4 for ARTV Artiva Biotherapeutics, Inc.
Accepted 2025-08-18 00:00:00 ET · period of report 2025-05-15 · accession 0001415889-25-022223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-18 | 2025-05-15+ | ARTV | Raymon Heather | SVP, Research, Development | F - Tax | $2.56 | -2,384 | 41.0K | -5% | -$6,094 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-15 | F | D | 745 | $2.13 | 42,605 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. |
| 2 | Common | Common Stock | 2025-08-15 | F | D | 1,639 | $2.75 | 40,966 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. |